Patients should be counseled to recognize symptoms of pancreatitis, including persistent severe abdominal pain that may radiate to the back, often accompanied by nausea and vomiting
Glucagon-like peptide-1 (GLP-1), as one of the important targets for the treatment of type 2 diabetes mellitus (T2DM), has obvious therapeutic effect, short half-life and easy to be cleared
GLP-1 helps regulate blood sugar levels by stimulating the release of insulin, suppressing glucagon secretion (which raises blood sugar levels), and slowing the rate at which the stomach empties, leading to a feeling of fullness and reduced appetite
Injections are subcutaneous into the abdomen, thigh, or upper arm
For optimal results, consume with a meal
The tablets are imprinted with 5 on one side and 4215 on the reverse side in blue ink 15,16